The combination of ALBI and AFP response: A small step forward in HCC von Chan, Landon L., Chan, Stephen L.

Volltext

The evolving role of lenvatinib at the new era of first-line hepatocellular carcinoma treatment von Chan, Landon L., Chan, Stephen L.

Volltext

Whole-genome bisulfite sequencing of multiple individuals reveals complementary roles of promoter and gene body methylation in transcriptional regulation von Lou, Shaoke, Lee, Heung-Man, Qin, Hao, Li, Jing-Woei, Gao, Zhibo, Liu, Xin, Chan, Landon L, Kl Lam, Vincent, So, Wing-Yee, Wang, Ying, Lok, Si, Wang, Jun, Ma, Ronald Cw, Tsui, Stephen Kwok-Wing, Chan, Juliana Cn, Chan, Ting-Fung, Yip, Kevin Y

Volltext

Drug Treatment for Advanced Hepatocellular Carcinoma: First-Line and Beyond von Feng, Maple Ye, Chan, Landon L, Chan, Stephen Lam

Volltext

The prime time for management of hepatocellular carcinoma in Hong Kong von Chan, Landon L, Chan, Stephen L

Volltext

A phase II clinical study on the efficacy and predictive biomarker of pegylated recombinant arginase on hepatocellular carcinoma von Chan, Stephen L., Cheng, Paul N.M., Liu, Angela M., Chan, Landon L., Li, Leung, Chu, Cheuk M., Chong, Charing C.N., Lau, Yat M., Yeo, Winnie, Ng, Kelvin K.C., Yu, Simon C.H., Mok, Tony S.K., Chan, Anthony W.H.

Volltext

Next-generation immunotherapy: igniting new hope for lung cancer von Li, Molly S. C., Chan, Andrew L. S., Mok, Kevin K. S., Chan, Landon L., Mok, Tony S. K.

Volltext

Drug development for hepatocellular carcinoma von Chan, Landon L, Chan, Stephen L

Volltext

Radiotherapy following intrahepatic progression on immunotherapy in advanced hepatocellular carcinoma von Chan, Landon L., Mok, Kevin, Chan, Stephen L.

Volltext

Biochemical response to ursodeoxycholic acid predicts survival in a North American cohort of primary biliary cirrhosis patients von Lammert, Craig, Juran, Brian D., Schlicht, Erik, Chan, Landon L., Atkinson, Elizabeth J., de Andrade, Mariza, Lazaridis, Konstantinos N.

Volltext

Brief Report: Risk of Recurrent Interstitial Lung Disease From Osimertinib Versus Erlotinib Rechallenge After Symptomatic Osimertinib-Induced Interstitial Lung Disease von Li, Molly S.C., Lee, Kirsty W.C., Mok, Kevin K.S., Loong, Herbert H.F., Lam, K.C., Mok, Florence S.T., Chan, Landon L., Lau, Y.M., Chan, K.P., Ng, Joyce T.Y., Wong, Wesley K.Y., Lam, Benjamin H.W., Chen, Allen C.C., Lee, Matthew M.P., Chen, Olivia H., Mok, Tony S.K.

Volltext

Multicentre phase II trial of cabozantinib in patients with hepatocellular carcinoma after immune checkpoint inhibitor treatment von Chan, Stephen L., Ryoo, Baek-Yeol, Mo, Frankie, Chan, Landon L., Cheon, Jaekyung, Li, Leung, Wong, Kwan H., Yim, Nicole, Kim, Hyeyeong, Yoo, Changhoon

Volltext

Novel Perspectives in Immune Checkpoint Inhibitors and the Management of Non-Alcoholic Steatohepatitis-Related Hepatocellular Carcinoma von Chan, Landon L, Chan, Stephen L

Volltext

Organ‐specific responses to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma: A multicentre, retrospective study von Cheon, Jaekyung, Jung, Sanghoon, Kim, Jung Sun, Kang, Beodeul, Kim, Hyeyoung, Chan, Landon L., Becker, Lars, Gaillard, Vincent E., Chan, Stephen L., Kim, Chan, Chon, Hong Jae

Volltext

Bioinformatics analysis of circulating cell-free DNA sequencing data von Chan, Landon L., Jiang, Peiyong

Volltext

The evolving role of lenvatinib at the new era of first-line hepatocellular carcinoma treatment von Chan, Landon L., Chan, Stephen L.

Volltext

Osimertinib-Related QTc Prolongation: Real-World Incidence and Impact of Drug Dosing on Recurrence Risk von Chen, Olivia H., Wong, Wesley K.Y., Mok, Kevin K.S., Chan, Landon L., Tang, Candy, Li, Molly S.C.

Volltext

Real-world outcomes of pemetrexed-platinum chemotherapy plus osimertinib after progression on first-line osimertinib in advanced EGFR-mutated NSCLC von Saw, Stephanie P.L., Low, Yi Fen, Lai, Gillianne G.Y., Chan, Landon L., Wong, Wesley K.Y., Tsui, Giselle, Chen, Olivia H., Seet, Amanda O.L., Tan, Wei Chong, Tan, Aaron C., Chan, Johan W.K., Teh, Yi Lin, Tan, Wan-Ling, Ng, Quan Sing, Ang, Mei-Kim, Kanesvaran, Ravindran, Lim, Darren W.T., Tan, Daniel S.W., Mok, Tony S.K., Li, Molly S.C.

Volltext

Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 a... von Juran, Brian D, Hirschfield, Gideon M, Invernizzi, Pietro, Atkinson, Elizabeth J, Li, Yafang, Xie, Gang, Kosoy, Roman, Ransom, Michael, Sun, Ye, Bianchi, Ilaria, Schlicht, Erik M, Lleo, Ana, Coltescu, Catalina, Bernuzzi, Francesca, Podda, Mauro, Lammert, Craig, Shigeta, Russell, Chan, Landon L, Balschun, Tobias, Marconi, Maurizio, Cusi, Daniele, Heathcote, E Jenny, Mason, Andrew L, Myers, Robert P, Milkiewicz, Piotr, Odin, Joseph A, Luketic, Velimir A, Bacon, Bruce R, Bodenheimer, Jr, Henry C, Liakina, Valentina, Vincent, Catherine, Levy, Cynthia, Franke, Andre, Gregersen, Peter K, Bossa, Fabrizio, Gershwin, M Eric, deAndrade, Mariza, Amos, Christopher I, Lazaridis, Konstantinos N, Seldin, Michael F, Siminovitch, Katherine A

Volltext

A network approach to exploring the functional basis of gene-gene epistatic interactions in disease susceptibility von Yip, Danny Kit-Sang, Chan, Landon L, Pang, Iris K, Jiang, Wei, Tang, Nelson L S, Yu, Weichuan, Yip, Kevin Y

Volltext